君实生物:20亿元中期票据获批注册

财中社
Dec 25, 2025

  12月25日,君实生物(688180/01877)发布公告,中国银行间市场交易商协会决定接受公司科技创新债券注册。

  此次注册的基础品种为中期票据,注册金额为20亿元,注册额度自通知书落款之日起2年内有效,主承销商为上海银行(601229)。

  2025年前三季度,君实生物实现收入18.06亿元,归母净利润-5.96亿元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10